ArticleInternational journal of obesity (2005)2026
Epigenetic age acceleration and metabolic syndrome among Hispanic/Latino adults: Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Article in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionWe tested the bidirectional association between epigenetic age acceleration (EAA), a marker of biological aging, and metabolic syndrome (MetS), a cluster of conditions that together increase the risk of type 2 diabetes, cardiovascular disease, and other chronic conditions, at different time points.
methodsA random sample of 962 Hispanic/Latino adults participating in the Hispanic Community Health Study/Study of Latinos were included in the analyses. At baseline, the mean age was 44.8 years, 61.5% of participants were female, and prevalence of MetS was 35.4%. DNA methylation was measured from whole blood, at two different time points six years apart, using the Illumina EPIC BeadChip and epigenetic age and EAA were calculated using the PhenoAge, GrimAge, and DunedinPACE algorithms. MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III guidelines, in which a diagnosis is met when participants meet at least 3 of the 5 conditions: elevated waistline/abdominal obesity, high blood pressure, high blood sugar levels, high blood triglycerides, and low high-density lipoprotein (HDL) cholesterol.
resultsIn cross-sectional analyses, higher PhenoAA (PR, 95% CI: 1.03, 1.01, 1.05), GrimAA (PR, 95% CI: 1.05, 1.01, 1.09), and DunedinPACE values (PR, 95% CI: 1.03, 1.02, 1.04) were associated with higher MetS prevalence. Over an average follow-up of six years, higher DunedinPACE values at baseline were associated with higher risk of incident MetS (Risk Ratio (RR), 95% CI: 1.04, 1.02, 1.05). Faster DunedinPACE rates (vs. average) were associated with higher risk of incident MetS (RR, 95% CI: 1.44, 1.07, 1.94), whereas slower DunedinPACE rates (vs. average) were associated with lower risk (RR, 95% CI: 0.44, 0.23, 0.87).
conclusionThe study suggests EAA is a potential indicator of both prevalent and incident MetS among Hispanic/Latino adults.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.